MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Parkinson’s Disease – The Unseen Side of Neurologic Chronic Illnesses – The Non-Motor World of Our Existence

    J. Baumann (Louisville, KY, USA)

    Objective: As an inspirational patient speaker who has lived, really lived, with Parkinson's disease for over 20 years, my first objective is to give the…
  • MDS Virtual Congress 2020

    Non-motor Symptoms in Advanced- vs Non-advanced Parkinson’s Disease: A Subgroup Analysis of the OBSERVE-PD Observational Study

    A. Fasano, L. Bergmann, V. SC Fung, K. Onuk, K. Seppi, Z. Pirtosek (Toronto, ON, Canada)

    Objective: To report intercountry differences in non-motor symptoms in patients with advanced Parkinson’s Disease (APD) vs non-APD. Background: There is no standard criteria for the…
  • MDS Virtual Congress 2020

    Alexithymia is associated with worse quality of life and caregiver burden in people with Parkinson’s disease

    M. Klietz, T. Schnur, S.C Drexel, F. Lange, L. Paracka, D. Dressler, G.U Höglinger, F. Wegner (Hannover, Germany)

    Objective: Aim of the present study was to determine the relationship of alexithymia on HR-QoL of the PwP and caregiver burden of the corresponding primary…
  • MDS Virtual Congress 2020

    Approach to the patients with the hallucinations, in the Parkinson’s disease in the low-income country and environment of restricted medications and stigmas

    B. Mukhammedaminov (Tashkent, Uzbekistan)

    Objective: Expose the percentage of patients with hallucinations in studying group of Parkinson’s disease patients in Uzbekistan. Background: Uzbekistan has 35 million population, largest in…
  • MDS Virtual Congress 2020

    Sleep Disturbances in Young Onset Parkinson’s Disease

    A. Patwardhan, P. Pal, N. Kamble, R. Yadav (Bangalore, India)

    Objective: To assess the quality of sleep, incidence of RBD and excessive daytime sleepiness in Young Onset Parkinson’s disease patients. Background: Sleep disorders are one…
  • MDS Virtual Congress 2020

    Vitamin Deficiencies in Parkinson’s Disease: A Case for Routine Screening

    E. Smith, J. Paseka, D. Torres-Russotto, D. Bhatti, J. Bertoni (Omaha, NE, USA)

    Objective: Assess the prevalence and impact of vitamin deficiencies in Parkinson’s Disease (PD) and how nutritional intake correlates with serum levels. Background: Previous research has…
  • MDS Virtual Congress 2020

    Insomnia may have a mediating role in linking Parkinson’s disease severity to depression and anxiety

    G. Yeganyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: The aim of this study was to investigate the role of insomnia in relationship of disease severity with depression/anxiety in patients with Parkinson’s disease…
  • MDS Virtual Congress 2020

    Selective α-synuclein overexpression-induced pathology in noradrenergic neurons: a new mouse model for prodromal Parkinson’s disease?

    B. Lee, Y. Chen, G. Ganjam, N. Decher, A. Gundlfinger, W.J Berg, M. Britschgi, O. Oertel (Marburg, Germany)

    Objective: To investigate the phenotype of noradrenergic (NA) neurons in an animal model with selective overexpression of α-synuclein (αSyn) in the locus coeruleus (LC) with…
  • MDS Virtual Congress 2020

    Spreading ɑ-synuclein pathology initiated from the sublaterodorsal tegmental nucleus models RBD followed by Parkinsonian phenotypes in mice

    Y. Shen, W.B Yu, B. Shen, H. Dong, J. Zhao, Y. Fan, Y.F Yang, Y.M Sun, Y.L Tang, F.T Liu, JJ. Wu, B.G Xiao, H. Yu, J. Koprich, Z.L Huang, J. Wang (Shanghai, China)

    Objective: To recapitulate ɑ-synucleinopathy based RBD-like behaviors in mice which could further proceed to develop Parkinsonian behavioral and histopathological phenotypes. Background: Idiopathic REM sleep behavior…
  • MDS Virtual Congress 2020

    Profiling Atypical Anxiety in Parkinson’s Disease

    E. Forbes, G. Byrne, J. O'Sullivan, J. Yang, N. Dissanayaka (St Lucia, Australia)

    Objective: We aimed to identify the demographic, psychiatric, clinical and cognitive characteristics associated with Anxiety not otherwise specified (NOS) in persons with Parkinson’s disease (PWP).…
  • « Previous Page
  • 1
  • …
  • 57
  • 58
  • 59
  • 60
  • 61
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley